Lexicon Pharmaceuticals, Inc. Common Stock (LXRX)
Since Aug 02, 2021, Lexicon Pharmaceuticals, Inc. Common Stock (LXRX) has reported earnings 21 times. On average the shares move ±10.56% post-earnings, with a positive reaction 57.1% of the time. Its largest post-earnings gain was +31.16% (Mar 11, 2024) and its largest decline was -27.07% (Feb 28, 2022). The next earnings report is predicted for 2026-11-09 (approximate).
Earnings reactions
How LXRX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±10.56%
Positive %
57.1%
Negative %
42.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☀ PRE | -4.66% | open_in_new |
| May 07, 2026 | ☀ PRE | +4.35% | open_in_new |
| Mar 05, 2026 | ☀ PRE | +0.31% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +3.27% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±10.56%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| EFFECT | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| S-3 | 20260806 | open_in_new SEC.gov |
| S-8 | 20260806 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260806 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
| 4 | 20260604 | open_in_new SEC.gov |
Frequently asked about LXRX earnings
When does Lexicon Pharmaceuticals, Inc. Common Stock report earnings next? expand_more
Lexicon Pharmaceuticals, Inc. Common Stock (LXRX)'s next earnings date is approximate for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LXRX stock move after earnings? expand_more
Over 21 reports, LXRX has moved an average of ±10.56% the session after earnings, closing higher 57.1% of the time.
What was LXRX's biggest post-earnings move? expand_more
LXRX's largest post-earnings gain on record was +31.16% on Mar 11, 2024, and its largest decline was -27.07% on Feb 28, 2022.
Where can I find Lexicon Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more
All of Lexicon Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right